Stay updated with breaking news from Topridge Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading investors with more than $15 trillion of assets under management participated in the meeting. RDIF presented 25 pharmaceutical companies that have partnered with the Fund for production
China and Russia want to vaccinate the developing world before the West. It's brought them closer than ever CNN 1 hr ago Analysis by Ben Westcott, CNN © Mikhail Svetlov/Getty Images Russian President Vladimir Putin (left) and Chinese President Xi Jinping at a welcoming ceremony on November 14, 2019 in Brasilia, Brazil. When Russia's Sputnik V vaccine is unloaded in countries around the world, hundreds of millions of doses will come with the label "Made in China." Chinese companies have made agreements over the past month to manufacture more than 260 million doses of Russi...
endIndex: (CNN) — When Russia's Sputnik V vaccine is unloaded in countries around the world, hundreds of millions of doses will come with the label "Made in China." Chinese companies have made agreements over the past month to manufacture more than 260 million doses of Russia's Sputnik V vaccine, which has been approved for use in more than 60 countries, including a large number of developing nations such as Mexico, India and Argentina. The deals are symbolic of how China and Russia's international vaccine goals are increasingly aligned, as they assist developing countries neglected by th...
2021-05-09 18:57 By: Xinhua Photo taken on April 28, 2021 shows the COVID-19 vaccines "Sputnik V" in Moscow, Russia. [Photo/Xinhua] MOSCOW - The Russian Direct Investment Fund (RDIF) has signed deals with three Chinese biopharmaceutical companies for the production of over 260 million doses of its Sputnik V vaccine against the coronavirus in the past weeks, according to statements published on the website of the RDIF. The first contract was signed with China's Shenzhen Yuanxing Gene-tech Co., Ltd. on March 29 for the production of over 60 ...
2021-05-07 15:35:20 GMT2021-05-07 23:35:20(Beijing Time) Xinhua English Photo taken on April 28, 2021 shows the COVID-19 vaccines "Sputnik V" in Moscow, Russia. (Xinhua/Evgeny Sinitsyn) MOSCOW, May 7 (Xinhua) -- The Russian Direct Investment Fund (RDIF) has signed deals with three Chinese biopharmaceutical companies for the production of over 260 million doses of its Sputnik V vaccine against the coronavirus in the past weeks, according to statements published on the website of the RDIF. The first contract was signed with China's Shenzhen Yuanxing Gene-tech Co., Ltd. on...